Parabilis, fresh from inking Regeneron pact, plans IPO to fund tumor drug’s phase 3 push Read more →

Pfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief Read more →

Clinical trial flaws ‘being scaled, not solved’ by AI: report Read more →